• Riverside Partners appointed J. Mark King as president, CEO of KMM Group following RS2 Healthcare Partners’ investment completion.
• King previously served as president, CEO of Tegra Medical, a medical device contract manufacturer formerly backed by RS2 Healthcare Partners.
• KMM co-founder John Shegda will move to chief technology officer, leading engineering and technology strategy.
• Co-founder Eric Wilhelm was named executive vice president, business transformation and organizational capability, overseeing operational excellence and scalable growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Riverside Partners LLC published the original content used to generate this news brief on September 24, 2026, and is solely responsible for the information contained therein.